Agiclob S (Skin) (15 gm) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Agio Pharmaceuticals Limited. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Clobetasol Propionate, Salicylic Acid. This drug comes in the form of Ointment. The general packing available for this medicine consists of 15 gm and is priced at Rs 55 (arround $0.77 US Dollar)
Clobetasol Propionate Indication (Prescribed for or used as): short-term ffeatment only of severe resistant inflammatory skin disorders such as recalcitrant eczemas unresponsive to less potent corticosteroids; psoriasis
For more details on Clobetasol Propionate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Clobetasol Propionate..
Salicylic Acid Indication (Prescribed for or used as):
For more details on Salicylic Acid, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Salicylic Acid..
Agiclob S (Skin) (15 gm) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 5 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Agiclob S (Skin) (15 gm), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Clobetasol Propionate-0.05% w/w Salicylic Acid-3% w/w). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.